By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    An Expert’s Guide To Building and Improving Endurance
    June 30, 2022
    medical assistants
    What Do Medical Assistants Do On a Day to Day Basis?
    April 5, 2022
    superfoods to help with prostate health
    10 Healthy Foods That Can Help Protect Your Prostate
    August 29, 2022
    Latest News
    5 Steps to a Promising Career as a Healthcare Administrator
    August 3, 2025
    Why Custom Telemedicine Apps Outperform Off‑the‑Shelf Solutions
    July 20, 2025
    How Probate Planning Shapes the Future of Your Estate and Family Care
    July 17, 2025
    Beyond Nutrition: Everyday Foods That Support Whole-Body Health
    June 15, 2025
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    healthcare cost crisis
    What If the Health Care Cost Crisis Solves Itself?
    May 11, 2013
    Do You Need Life Insurance? What Does It Cover?
    December 23, 2022
    HIE metal plans
    The Four “Metal Plans” of Health Insurance Exchanges
    May 28, 2013
    Latest News
    How IT and Marketing Teams Can Collaborate to Protect Patient Trust
    July 17, 2025
    How Health Choices and Legal Actions Intersect After an Injury
    July 17, 2025
    How communities and healthcare providers can address slip and fall injuries with legal awareness
    July 17, 2025
    Let Your Lawyer Handle the Work Before You Pay Medical Costs
    July 6, 2025
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: BioPharma Beat: Incremental Innovation Is Sometimes What the Doctor Needs
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Medical Education > BioPharma Beat: Incremental Innovation Is Sometimes What the Doctor Needs
Medical EducationMedical InnovationsPublic HealthTechnologyWellness

BioPharma Beat: Incremental Innovation Is Sometimes What the Doctor Needs

David Davidovic
David Davidovic
Share
5 Min Read
biopharma beat incremental change healthcare
SHARE

Last month, we discussed the importance of imagination in the context of big and revolutionary ideas and how we need those ideas to truly innovate healthcare in a transformative way. The reality, however, is that coming up with those big, imaginative concepts is much easier said than done, and they are a rarity.

Of course, we should always want those big quantum ideas and solutions, but we should not forget that…

Last month, we discussed the importance of imagination in the context of big and revolutionary ideas and how we need those ideas to truly innovate healthcare in a transformative way. The reality, however, is that coming up with those big, imaginative concepts is much easier said than done, and they are a rarity.

Of course, we should always want those big quantum ideas and solutions, but we should not forget that…

More Read

What Can The New iPad Do For Healthcare?
Where the US Lags Italy in Healthcare
Can CBD Oil Be Used To Treat Inflammation? Here’s What To Know
Mass Immunization Efforts Get Help of Mobile App
How To Adopt The Right Mobile App Technology To Improve Healthcare

A lot of innovation in healthcare is incremental and progressive—and there is absolutely nothing wrong with baby steps.

biopharma beat incremental change healthcareOften, new drugs, devices or medical procedures are only marginally better than what is already available. Critics are very quick at calling these out as wasteful, expensive and unnecessary. When looking at a single, small evolutionary step very narrowly, they may have a good point. After all, going from a twice-a-day drug to a once-a-day drug with the same clinical profile (i.e., similar benefits and side effects) does seem like no change at all or little at best.

However, from time to time, we need to step back and look at bigger timeframes in which multiple relatively small, sequential innovations have taken place. Let’s pick on hypertension as an example. In the last few decades, we have seen the discovery, development and introduction of dozens of products in many classes and subclasses: diuretics, beta-blockers, calcium channel blockers, ACE inhibitors, angiotensin receptor blockers, renin inhibitors and more. Some have been better than others at their core job, i.e. to lower high blood pressure, or have offered particular benefits to specific patient populations (e.g., comorbidities, such as people with heart failure or renal impairment), but others have been marginally better, offering benefits like less frequent dosage or trading one bothersome side effect for another.

However, if we take a step back and look at hypertension management since the 1950s and see the point-to-point difference, the overall innovation has been dramatic. Who would want to go back to the use of reserpine, with its severe side effects, including its association with depression leading to suicide?

It would have been wonderful if, magically, science could have gone from reserpine to angiotensin receptor blockers, in one imaginative and disruptive giant step.

But this is an impossible wish. Basic science, the understanding of disease, the discovery of mechanisms and receptors and the advent of new research tools and methods all took a long time and a lot of blood, sweat and tears to evolve in labs across the world. We simply had to go through the journey, and, fortunately, the journey is not over because we need even better agents.

We see a similar journey in the world of cholesterol management. Going way back to disgusting powders that felt and tasted like sand to somewhat effective agents with many side effects to the statins that transformed cardiovascular risk management in dramatic ways, we’re benefiting from this incremental evolution. The new kids on the block are the PCSK-9 inhibitors with a lot of promise in lowering LDL cholesterol dramatically and also having positive effects on hospitalizations and mortality. Data and findings on these products are being presented at major meetings around the world, and the first products have been filed for regulatory approval. If successful, these should help continue the decline of devastating outcomes of cardiovascular disease.

We’ve come a long way indeed!

Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

technology in medical research
The Tools Helping Medical Researchers See the Full Picture
News Technology
August 3, 2025
5 Steps to a Promising Career as a Healthcare Administrator
5 Steps to a Promising Career as a Healthcare Administrator
Health
July 31, 2025
holistic dental
Holistic Dentist Services Are Natural and Safe
Dental health Specialties
July 28, 2025
botox certification
Help Improve People’s Skin Health Via Botox Certification
Skin Specialties
July 22, 2025

You Might also Like

More on the Longevity Project

March 17, 2011

Pharma and the Empowered, Educated Patient

September 20, 2011

One Health Insurer’s Strategy for Patient Engagement

September 10, 2014

Robots as Doctors

June 22, 2012
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?